| POLAR CAPITAL BIOTECHNOLOGY R USD DIS | RVI BIOTECNOLOGÍA | 81,15% | 98,64% | 98,53% | 394,24% |
| UBS (LUX) KEY SELECTION SICAV - EUROPEAN EQUITY VALUE OPPORTUNITY (EUR) P-ACC | RVI EUROPA CRECIMIENTO | 30,27% | 65,89% | 98,51% | 176,73% |
| BGF WORLD TECHNOLOGY D2 USD | RVI TECNOLOGÍA | 58,67% | 132,59% | 98,45% | 821,02% |
| M&G (LUX) JAPAN FUND USD C ACC | RVI JAPÓN | 45,14% | 68,11% | 98,40% | 214,12% |
| SCHRODER GAIA CONTOUR TECH EQUITY C ACC CHF (HEDGED) | RVI TECNOLOGÍA | 23,64% | 96,16% | 98,36% | · |
| MFS MERIDIAN BLENDED RESEARCH EUROPEAN EQUITY FUND AH1-USD | RVI EUROPA | 30,80% | 60,41% | 98,35% | 212,53% |
| FIDELITY FUNDS-GLOBAL TECHNOLOGY Y-ACC-EUR | RVI TECNOLOGÍA | 26,67% | 78,59% | 98,33% | 607,00% |
| M&G (LUX) EUROPEAN STRATEGIC VALUE FUND EUR B ACC | RVI EUROPA VALOR | 23,74% | 75,13% | 98,29% | · |
| BGF WORLD FINANCIALS C2 USD | RVI FINANCIERO | 23,60% | 109,18% | 98,15% | 318,76% |
| JPM KOREA EQUITY A (ACC) USD | RVI COREA | 124,62% | 163,48% | 98,08% | 309,90% |
| JANUS HENDERSON HF - GLOBAL TECHNOLOGY LEADERS I2 EUR HEDGED | RVI TECNOLOGÍA | 44,26% | 128,05% | 98,07% | 510,45% |
| POLAR CAPITAL BIOTECHNOLOGY R EUR DIS | RVI BIOTECNOLOGÍA | 80,64% | 98,65% | 98,07% | 392,42% |
| JPM GLOBAL NATURAL RESOURCES C (ACC) USD | RVI MATERIAS PRIMAS | 45,02% | 58,41% | 98,06% | 213,27% |
| POLAR CAPITAL BIOTECHNOLOGY R GBP DIS | RVI BIOTECNOLOGÍA | 79,34% | 98,49% | 98,01% | 391,07% |
| BLACKROCK EMERGING MARKETS EQUITY STRATEGIES X2 USD | RVI EMERGENTES | 34,54% | 67,68% | 97,98% | · |
| VANGUARD U.S. OPPORTUNITIES INSTITUTIONAL USD CAP | RVI USA | 58,85% | 90,43% | 97,97% | 358,99% |
| INVESCO PAN EUROPEAN EQUITY Z CAP USD (HEDGED) | RVI EUROPA | 34,89% | 50,97% | 97,96% | 195,66% |
| SCHRODER ISF FRONTIER MARKETS EQUITY B ACC USD | RVI EMERGENTES | 31,49% | 75,68% | 97,94% | 161,37% |
| BGF WORLD TECHNOLOGY D2 EUR | RVI TECNOLOGÍA | 58,05% | 132,72% | 97,93% | 818,03% |
| JPM GLOBAL NATURAL RESOURCES I (ACC) EUR | RVI MATERIAS PRIMAS | 44,58% | 58,70% | 97,92% | · |
